Table 2.
Baseline characteristics at the time of registration.
| Conv groupa (n = 21) |
SPL groupb (n = 21) |
p value | |
|---|---|---|---|
| Age (years) | 68.2 ± 7.2 | 66.3 ± 9.5 | .43a |
| Gender (male/female) | 12/9 | 11/10 | .65b |
| Duration of DM (years) | 12.5 ± 4.4 | 13.1 ± 5.9 | .38a |
| Hemoglobin A1c (%) | 7.3 ± 0.9 | 7.1 ± 1.1 | .51a |
| Insulin therapy | 9 (42.9%) | 10 (47.6%) | .34b |
| Left eye: right eye | 8 : 11 | 7 : 14 | .52b |
| Phakic eyes | 9 (42.9%) | 10 (47.6%) | .51b |
| The presence of diabetic macular edema (%) | 16 (76.1%) | 17 (81.0%) | .73b |
| Focal | 8 | 9 | |
| Diffuse | 8 | 8 |
aMann–Whitney test. bChi-square test. DM: diabetes mellitus; Conv: conventional; SPL: short-pulse laser.